Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-157
TNBC
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7498.091
uM
19.20760
26.21150
-0.9722 -0.9735 3.4764 0.4341
0.9980
1.1445
MDA-MB-157
TNBC
Basal B
Ispinesib
KSP
Kinesin
7496.067
uM
0.02684
0.03428
-0.9834 -0.5160 2.8953 0.7950
0.9351
1.1301
MDA-MB-157
TNBC
Basal B
Ispinesib
KSP
Kinesin
7495.067
uM
0.01568
0.02423
-0.9958 -0.5540 1.7154 0.8366
0.9375
1.1275
MDA-MB-157
TNBC
Basal B
Ispinesib
KSP
Kinesin
7498.067
uM
0.02986
0.03823
-0.9562 -0.5429 2.9754 0.8002
0.9495
1.1346
MDA-MB-157
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7498.095
uM
0.00281
0.00750
-0.9649 -0.6387 0.8396 1.0591
0.9477
1.2329
MDA-MB-157
TNBC
Basal B
Ixabepilone
TUBB
TUBB
7496.095
uM
0.00644
0.01443
-0.9956 -0.7973 1.1830 1.0717
0.9856
1.0348
MDA-MB-157
TNBC
Basal B
JNK-IN-5A
JNK
JNK
12594.168
uM
139.96220
172.43870
-0.3001 -0.9193 4.9998 0.0684
0.9948
1.2703
MDA-MB-157
TNBC
Basal B
L-779450
BRAF
MAPK
12594.166
uM
12.7230
26.42770
-0.1730 -1.0000 1.5029 0.1084
0.9879
1.0936
MDA-MB-157
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7495.098
uM
inf
inf
0.8940 0.8940 0.0000 0.0304
-0.0672
0.5841
MDA-MB-157
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7496.098
uM
38.65430
20.79910
0.7518 0.3611 2.0670 0.0410
0.6276
0.9037
MDA-MB-157
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7498.098
uM
inf
22.53420
0.8724 0.7240 0.6002 0.0132
0.6801
1.1057
MDA-MB-157
TNBC
Basal B
LBH589
HDAC
HDAC
12594.167
uM
0.05661
0.16043
-0.9295 -0.9883 1.0470 0.8179
0.9918
1.4099
MDA-MB-157
TNBC
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12594.167
uM
0.38176
1.83210
-0.9527 -1.0000 0.7004 0.4510
0.9495
1.4099
MDA-MB-157
TNBC
Basal B
Mebendazole
12632.174
uM
0.47426
1.51290
-0.7326 -0.7913 0.8179 0.5406
0.9867
0.8563
MDA-MB-157
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7498.084
uM
inf
0.02401
0.5364 0.5217 1.7317 0.3634
0.9346
1.1749
MDA-MB-157
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7496.085
uM
0.02709
0.02634
0.0403 0.0413 3.0536 0.7096
0.9894
1.0748
MDA-MB-157
TNBC
Basal B
Methylglyoxal
13611.184
uM
444.34060
663.74310
-0.9810 -0.8867 2.5419 0.7713
0.9453
0.8419
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
14218.189
uM
inf
inf
-0.3389 -0.3389 0.0000 0.6358
0.5723
1.3111
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
14218.189
uM
inf
inf
-0.3389 -0.3389 0.0000 0.6358
0.5723
1.3111
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
14931.189
uM
0.16304
0.18737
-0.9980 -0.5022 4.9995 0.8043
0.5910
0.6183
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
14931.189
uM
0.16304
0.18737
-0.9980 -0.5022 4.9995 0.8043
0.5910
0.6183
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
12594.17
uM
0.16250
0.26807
-0.9603 -0.9657 2.1485 0.8363
0.9991
1.2180
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
12594.17
uM
0.16250
0.26807
-0.9603 -0.9657 2.1485 0.8363
0.9991
1.2180
MDA-MB-157
TNBC
Basal B
Pevonedistat
NAE1
NAE1
12594.135
uM
0.06018
0.13884
-0.3682 -0.3641 0.6544 0.6524
0.9873
1.3446
MDA-MB-157
TNBC
Basal B
Nelfinavir
12632.174
uM
8.66770
10.84610
-0.9889 -0.9971 4.8914 0.1686
0.9955
0.8563